Friday, September 7, 2018

Shire willing to back $64 billion Takeda bid but market signals doubts

LONDON/NEW YORK/TOKYO (Reuters) – Rare disease specialist Shire said on Wednesday it was willing to recommend a sweetened $64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company this year.

 

copyright © 2018



from Shire willing to back $64 billion Takeda bid but market signals doubts
via Shire willing to back $64 billion Takeda bid but market signals doubts September 07, 2018 at 01:25AM
RSS Feed

Regional Justice Center, Las Vegas Nevada Consumer Credit Counseling Service


Unsubscribe from these notifications or sign in to manage your Email Applets.

IFTTT

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.